The microbiopsy market size is projected to be worth USD 157.5 million in 2023. The market is likely to surpass USD 305.7 million by 2033 at a CAGR of 6.9% during the forecast period. The creation, manufacture, and distribution of microbiopsy equipment and associated goods are the primary objectives of the microbiopsy market, a subset of the medical diagnostics and research business.
For diagnostic or research reasons, microbiopsy involves the minimally invasive sample of body tissue or cells. Microbiopsies often get smaller tissue samples, which are less intrusive and uncomfortable for patients than standard biopsies, which remove larger tissue samples.
Other Drivers Propelling the Demand for Microbiopsy include:
Challenges for Companies /Manufacturers in the Microbiopsy Market:
Opportunities in the Microbiopsy Industry:
Latest Trends in the Microbiopsy Market:
| Attributes | Details |
|---|---|
| Microbiopsy Market Size (2023) | USD 157.5 million |
| Microbiopsy Market Projected Size (2033) | USD 305.7 million |
| Value CAGR (2023 to 2033) | 6.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global microbiopsy market experienced a CAGR of 5.1%, reaching a market size of USD 157.5 million in 2023.
A minimally invasive biopsy method called microbiopsy includes taking small tissue samples for analysis or research. Microbiopsy technique have evolved within the molecular diagnosis and research arena over the years. From 2012 to 2022, the market for microbiopsy tools and services has expanded steadily. Microbiopsy has been applied in various domain including infectious disease diagnosis like leishmaniasis or viral warts, skin oncology like basel cell carcinoma (BCC) and melanoma.
Future Forecast for Microbiopsy Industry:
Looking ahead, the global microbiopsy industry is expected to rise at a CAGR of 6.9% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 305.7 million by 2033.
Chronic diseases such as cancer, dermatological conditions, and autoimmune disorders are on the rise globally. Microbiopsy plays a crucial role in the early diagnosis, monitoring, and treatment of these conditions. As the prevalence of chronic diseases continues to increase, the demand for microbiopsy techniques and devices is expected to grow.
Technological advancements have led to the development of more advanced and precise microbiopsy devices. These devices offer improved accuracy, minimal tissue damage, and reduced patient discomfort. The introduction of automated and handheld microbiopsy devices has made the procedure more accessible and efficient. Ongoing research and development in the field are expected to drive further advancements, expanding the market.
| Country | The United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 96.3 million |
| CAGR % 2023 to End of Forecast (2033) | 6.4% |
The microbiopsy industry in the United States is expected to reach a market size of USD 96.3 million by 2033, expanding at a CAGR of 6.4%. Rising prevalence of cancer, which has led to a higher demand for accurate and minimally invasive diagnostic procedure. Along with technology advancement has contributed to the growth of global market growth.
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 15.6 million |
| CAGR % 2023 to End of Forecast (2033) | 6.3% |
The microbiopsy industry in the United Kingdom is expected to reach a market value of USD 15.6 million, expanding at a CAGR of 6.3% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing demand for microbiopsy by healthcare professionals. Also, UK has robust healthcare system with a high focus on innovation which created favorable environment for the growth of the microbiopsy market.
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 18.7 million |
| CAGR % 2023 to End of Forecast (2033) | 8.1% |
The microbiopsy industry in China is anticipated to reach a market size of USD 18.7 million, moving at a CAGR of 8.1% during the forecast period. The Chinese government is investing heavily in advancing healthcare infrastructure and technology in the country. Also, private healthcare expenditure on advanced diagnostics has contributed to the growth of microbiopsy market in China.
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 15.2 million |
| CAGR % 2023 to End of Forecast (2033) | 7.4% |
The microbiopsy industry in Japan is estimated to reach a market size of USD 15.2 million by 2033, thriving at a CAGR of 7.4%. Increasing adoption of robotics and biopsy procedures is driving the growth of the market in Japan. These advanced technologies offer greater precision and accuracy, while also reducing the risk of tissue damage and infection.
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 13.5 million |
| CAGR % 2023 to End of Forecast (2033) | 8.8% |
The microbiopsy industry in South Korea is expected to reach a market size of USD 13.5 million, expanding at a CAGR of 8.8% during the forecast period. The market in South Korea is forecasted to witness growth as government has implemented various initiatives to improve the country’s healthcare system. Also, the rising demand for personalized medicine in south Korea.
Principal Consultant
The microbiopsy needle is expected to dominate the microbiopsy industry with a CAGR of 8.2% from 2023 to 2033. Microbiopsy needles are made specifically to collect minute tissue samples from selected body parts. These needles include either a tiny needle tip or a cutting edge that allows for regulated and precise tissue collection. For precise diagnosis, research, and treatment planning, the capacity to acquire high-quality tissue samples with little damage or contamination is crucial. The improvement of tissue sampling made possible by microbiopsy needles is what is causing the microbiopsy market to expand.
The skin cancer segment is expected to dominate the microbiopsy industry with a CAGR of 8.2% from 2023 to 2033. One of the most prevalent cancers in the world is skin cancer, which includes melanoma and non-melanoma varieties such basal cell carcinoma and squamous cell carcinoma. A thorough and timely diagnosis is essential for efficient care and better patient outcomes. Tissue samples are typically obtained using microbiopsy procedures such skin punch biopsies or shave biopsies for histopathological analysis and conclusive diagnosis. The market for microbiopsy procedures is expanding as a result of the rising incidence of skin cancer and the increased demand for microbiopsy operations.
The hospital segment is expected to dominate the microbiopsy industry with a CAGR of 6.7% from 2023 to 2033. Key centers for diagnostic services, such as microbiopsy procedures, are hospitals. Hospitals offer the required equipment, knowledge, and resources to conduct microbiopsy operations when patients present with questionable skin lesions or need tissue collection for diagnostic purposes. Specialized dermatological departments, pathology labs, and qualified medical staff that perform and analyses microbiopsy results are all found in hospitals. The need for microbiopsy procedures is driven by hospitals' accessibility to complete diagnostic services, which also helps the market expand.
The microbiopsy sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
The microbiopsy sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Mergers and acquisitions are frequently used by key players in the microbiopsy business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Microbiopsy Market:
The market is forecast to record a CAGR of 6.9% through 2033.
The market is valued to attain USD 305.7 million by 2033.
The market is estimated to secure a valuation of USD 157.5 million in 2023.
The China market is to flourish at an 8.1% CAGR.
With a CAGR of 8.2%, the microbiopsy needle category takes precedence in the market.
The market in the United States is to develop at a CAGR of 6.4%.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product 9.1. Needle 9.2. Forceps 9.3. Devices 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication 10.1. Skin cancer 10.2. Actinic keratosis 10.3. Dermatitis 10.4. Others 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 11.1. Hospitals 11.2. Specialty Clinics 11.3. Cancer Institutes 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. South Asia 12.5. East Asia 12.6. Oceania 12.7. Middle East and Africa (MEA) 13. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 20. Market Structure Analysis 21. Competition Analysis 21.1. Trajan Scientific Australia Pty Ltd. 21.2. Vigeo 21.3. Zamar Biopsy 21.4. Medax 21.5. AprioMed 21.6. Hologic 21.7. Mammotome 21.8. M.D.L. 21.9. Histo 21.10. Changzhou Mingle Medical Equipment Co., Ltd. 21.11. Surtex Instruments Limited 21.12. STERIS 21.13. MICRO-TECH EUROPE 21.14. Boston Scientific Corporation 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Microbiopsy Market
